| Literature DB >> 30397494 |
Saima Hasan1, Sian M Shaw1, Leslie H Gelling1, Catherine J Kerr2, Catherine A Meads1.
Abstract
OBJECTIVE: Type 1 diabetes mellitus rates are rising worldwide. The health benefits of physical exercise in this condition are many, but more than 60% do not participate, mainly from fear of hypoglycemia. This systematic review explores the effects of physical exercise modes on blood glucose levels in adults for hypoglycemia prevention. RESEARCH DESIGN AND METHODS: Predefined inclusion criteria were randomized or non-randomized cross-over trials of healthy non-obese adults with type 1 diabetes mellitus. Exercise interventions used standardized protocols of intensity and timing. Outcomes included hypoglycemia during or after exercise, and acute glycemic control. Medline, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, SPORTDiscus, CochraneCENTRAL (1990 to 11 January 2018), and Embase (1988 to 9 April 2018) were searched using keywords and Medical Subject Heading (MeSH) terms. Inclusions, data extraction and quality assessment using the Critical Appraisal Skills Programme checklists were done by one researcher and checked by a second. Review Manager (V.5.3) was used for meta-analysis where four or more outcomes were reported.Entities:
Keywords: exercise; hypoglycaemia; systematic review; type 1 diabetes mellitus
Year: 2018 PMID: 30397494 PMCID: PMC6203053 DOI: 10.1136/bmjdrc-2018-000578
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Study characteristics
| Study | Study design | Exercise intervention type, duration (min), description, intensity | Comparator | Timing of blood glucose measurements |
| Bally | Randomized cross-over trial | Cycling at 50% VO2max for 90 min with IHE with 9×10 s maximal sprints every 10 min at 120% of individual peak workload followed by 50 s recovery phase. | Cycling at 50% VO2max for 90 min. | During 90 min of exercise, 120 min postexercise and postexercise overnight follow-up. |
| Campbell | Randomized cross-over trial | Intermittent running (Shuttle Test): 3×20 m walking then 1×20 m sprinting, interspersed by 4 s recovery, followed by 3×20 m run (speed corresponding to 55% VO2max) and 3×20 m (speed equating to 95% VO2peak) repeated for 45 min. | Continuous treadmill running at 77% VO2max for 45 min. | During, 1 hour and 23 hours postexercise. |
| Dubé | Randomized cross-over trial | Cycling at 50% VO2max for 60 min with 10 s maximal sprint every 2 min. | Cycling at 50% VO2max for 60 min.* | During exercise. |
| Guelfi | Randomized cross-over trial | Cycling at 40% VO2max for 30 min with 16×4 s maximal sprints every 2 min. | Cycling at 40% VO2max for 30 min. | During and up to 60 min of recovery or until BG falls <4 mmol/L. |
| Hinojosa and Heiss | Cross-over trial | Walking at 50%–60% maximum heart rate for 15 min. | Sitting quietly. | During and up to 120 min following exercise. |
| Iscoe and Riddell | Randomized cross-over trial | Cycling at 50% VO2max with 9×15 s maximal sprints every 5 min. | Cycling at 55% VO2max. | During and up to 24 hours following exercise. |
| Jankovec | Randomized cross-over trial | Cycling at 60% hour reserve for 2×30 min. | Resting. | During exercise. |
| Maran | Randomized cross-over trial | Cycling at 40% VO2max with 15×5 s maximal sprints at 85%. | Cycling at 40% VO2max. | During and up to 24 hours following exercise. |
| Moser | Cross-over trial | Cycling at control A, B or C followed by 120 s, 60 s or 20 s recovery period, followed by high-intensity peak workload (PPeak) for 20 s (followed by 3 s active recovery at 40W and 3 s passive recovery at 0W). | Cycling at 3 target workloads: | During and 24 hours postexercise. |
| Peter | Randomized cross-over trial | Cycling at 65% (SD 10.1%) VO2peak. | Resting. | During and |
| Rabasa-Lhoret | Randomized cross-over trial | Cycling at 25%, 50%, or 75% VO2max for 30 or 60 min. | Resting. | During exercise (30 and 90 min), 18 hours postexercise and at rest. |
| Soo | Randomized partial cross-over trial | Cycling at 60% VO2max (50% hour reserve) for 45 min. | Resting. | During and 60 min following exercise. |
| Turner | Randomized cross-over trial | Lifting weights for 14 min (1 set of 8 exercises), 28 min (2 sets) or 42 min (3 sets). | Resting for 14 min. | At rest and up to 60 min of recovery postexercise. |
| Yamanouchi | Cross-over trial | Walking at <50% VO2max for 30 min. | Resting. | During and 2 hours, postexercise. |
| Yardley | Part-randomized cross-over trial |
Weightlifting: 3 sets (7 exercises ×8 repetitions). Walking/running at 60% VO2max for 45 min. | Resting. | During exercise, 6 hours postexercise and 24 hours postexercise. |
*Third exercise condition excluded as not comparable.
BG, blood glucose; IET, incremental exercise test; IHE, intermittent high-intensity exercise; PLTP1, power output at the first lactate turn point; PLTP2, power output at the second lactate turn point; Pmax, maximal power output; VO2max, maximal oxygen uptake; VO2peak, peak oxygen uptake; W, watt.
Participant characteristics
| Study | Participants | Age (years) | BMI | Duration of diabetes (years) | HbA1C
| Baseline VO2max (mL/kg/min) |
| Bally | 12 (all M) | 26.2 (3.9) | 25.2 (3.4) | 14.2 (6.2) | 7 (0.6) | 47.9 (10.2) |
| Campbell | 9 (7M/2F) | 35 (4.0) | 26.8 (1.1) | 25 (4) | 8.1 (0.2) | 41.8 (1.6) |
| Dubé | 11 (5M/6F) | 26.5 (6.6) | 25.8 (2.7) | 12.2 (5.1) | 7.3 (0.4) | 33.4 (6.5) |
| Guelfi | 7 (4M/3F) | 21.6 (4.0) | 24.7 (3.7) | 8.6 (5.0) | 7.4 (1.5) | 39.3 (7.4) |
| Hinojosa and Heiss | 7 (4M/3F) | 22.3 (4.3) | 25.4 (3.5) | 12.7 (3.5) | 7.4 (0.5) | NR |
| Iscoe and Riddell | 11 (5M/6F) | 35.1 (3.5) | NR | 15.6 (5.6) | 7.8 (0.4) | 42.4 (1.6) |
| Jankovec | 12 (all M) | 33.4 (8.47) | 25.8 (3.67) | 16.4 (8.57) | 8.4 (0.95) | NR |
| Maran | 8 (all M) | 34 (7) | 24 (2) | 14.3 (8) | 7.14 (0.6) | 33.7 (6.5) |
| Moser | 7 (all M) | 24 (5.3) | 23.9 (2.5) | >1 years | 7.4 (0.6) | 52 (8.2) |
| Peter | 13 (12M/1F) | 33.3 (6.5) | 26.8 (3.3) | ≥1 years | 7.6 (1.3) | NR |
| Rabasa-Lhoret | 8 (all M) | 33 (8.8) | 23.4 (1.7) | 12.6 (8.8) | 6.1 (0.006) | 37.8 (3.5) |
| Soo | 9 (8M/1F) | 25.8 (7.0) | 22.8 (1.2) | 7.3 (5.7) | NR | NR |
| Turner | 8 (7M/1F) | 38 (6) | 26.9 (1.5) | 15 (4.5) | 8.7 (1.0) | NR |
| Yamanouchi | 6 (3M/3F) | 42.7 (13.6) | 20.3 (2.3) | 5.6 (6.4) | 7.4 (0.9) | NR |
| Yardley | 12 (10M/2F) | 31.8 (15.3) | 25.3 (3) | 12.5 (10) | 7.1 (1.1) | 51.2 (10.8) |
BMI, body mass index; F, female; HbA1C, glycosylated hemoglobin; M, male; NR, not recorded; VO2max, maximal oxygen uptake.
Results: hypoglycemia incidents in intervention compared with con
| IHE compared with continuous exercise | |||||
| Study | Hypos (n) during/after IHE | Hypos (n) during/after continuous exercise | Evening or nocturnal hypos (n) (or mean (SD)) | Evening or nocturnal hypos (n) (or mean (SD)) | Definition of hypoglycemia |
| Bally | None* | None* | 1.18 (0.42)† | 0.58 (0.32) † | BG <4 mmol/L |
| Campbell | 1 hour postexercise: 2/9 (22%) | 1 hour postexercise: 3/9 (33%) | 6/9 (67%) | 6/9 (67%) | BG <3.5 mmol/L |
| Dubé | 4/11 (36%) | 7/11 (64%) | Noct 0.3 (0.5) | Noct 0.3 (0.5) | BG <4 mmol/L |
| Guelfi | 1/7 (14%) | 2/7 (29%) | NR | NR | BG <4 mmol/L |
| Iscoe and Riddell | 3/11 (27%) | 7/11 (64%) | Evening 3/11 (27%) | Evening 5/11 (45%) | BG <4 mmol/L |
| Maran | 7/8 (87%) | 2/8 (25%) | NR | NR | Interstitial glucose <60 mg/dL |
| Moser | None | None | None | None | BG <3.3 mmol/L |
*Third exercise condition excluded as not comparable.
†64% observed hypos above 3 mmol/L.
‡Episodes of hypoglycemia not described per person.
BG, blood glucose; hypos, hypoglycemic episodes; noct, nocturnal; NR, not recorded.
Figure 1Meta-analysis of hypoglycemic episodes in intermittent high-intensity exercise (IHE) versus continuous exercise control. M-H, Mantel-Haentzel.